Yu-Hsin Lin insider trades: Belite Bio (BLTE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yu-Hsin reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | BLTE | ↓ Sell | 365 | $180.35 | $66K | Direct | Aug 14, 2026 (2d) |
| Apr 9, 2026 | BLTE | ↓ Sell | 9,200 | $181.45 | $1.7M | Direct | Apr 13, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other BLTE insiders
Open-market trades in the last 12 months
About Yu-Hsin Lin's insider trades
Yu-Hsin Lin is Chief Executive Officer at Belite Bio (BLTE). Since Apr 9, 2026, Yu-Hsin has reported no open-market purchases and 2 sales worth $1.7M on SEC Form 4. In the last 12 months: 2 sales ($1.7M).
Their filings also include other transactions (2 filings), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BLTE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.